サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1761081

安定同位体標識化合物の世界市場

Stable Isotope Labeled Compounds

出版日
ページ情報
英文 408 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
安定同位体標識化合物の世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 408 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

安定同位体標識化合物の世界市場は2030年までに4億3,250万米ドルに達する見込み

2024年に3億4,350万米ドルと推定される安定同位体標識化合物の世界市場は、2024年から2030年にかけてCAGR 3.9%で成長し、2030年には4億3,250万米ドルに達すると予測されます。本レポートで分析されているセグメントの1つである重水素は、CAGR 4.9%を記録し、分析期間終了時には1億8,340万米ドルに達すると予想されています。酸素-18セグメントの成長率は、分析期間でCAGR 4.0%と推定されます。

米国市場は1億2,900万米ドルと推定、中国はCAGR6.1％で成長予測

米国の安定同位体標識化合物市場は、2024年に1億2,900万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.1%として、2030年までに3,300万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7％と3.7％と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の安定同位体標識化合物市場- 主要動向と促進要因まとめ

安定同位体標識化合物は、医薬品、環境調査、代謝研究など、さまざまな科学的・産業的アプリケーションにおいて重要なツールです。炭素13、窒素15、酸素18、重水素などの非放射性同位体で標識されたこれらの化合物は、研究者が複雑な生化学的・化学的プロセスを高精度で追跡・調査することを可能にします。安定同位体の使用は、反応メカニズム、代謝経路、薬物相互作用に関する詳細な洞察を提供し、生物学的システムや環境動態の理解を大きく前進させる。放射性同位体とは異なり、安定同位体は放射線の危険性がないため、実験室や産業環境での広範な使用において、より安全で汎用性の高いものとなっています。

安定同位体標識化合物の市場は、医薬品の研究開発における需要の高まりにより拡大しています。これらの化合物は、新薬の合成や試験において不可欠であり、治療薬の薬物動態や代謝運命の決定に役立っています。環境科学の分野では、安定同位体は栄養サイクル、炭素の流れ、汚染源の追跡に使用され、生態学的研究や環境モニタリングに不可欠なデータを提供しています。核磁気共鳴（NMR）や質量分析などの高度な分析技術の出現により、安定同位体標識化合物の有用性はさらに高まり、より精密で包括的な分析が可能になりました。

安定同位体標識化合物市場の成長は、いくつかの要因によって牽引されています。第一に、医薬品研究開発への投資の増加が、医薬品開発や代謝研究におけるこれらの化合物の需要を押し上げています。第二に、質量分析とNMRにおける感度と分解能の向上などの分析技術の進歩が、安定同位体標識化合物の用途を拡大しています。第三に、環境の持続可能性への関心の高まりと正確な生態学的モニタリングの必要性が、環境研究における安定同位体の使用を促進しています。最後に、医薬品承認プロセスにおける詳細な代謝および薬物動態データに対する規制要件が、市場の成長をさらに促進しています。これらの要因が総合的に安定同位体標識化合物市場の堅調な拡大に寄与しています。

セグメント

タイプ（重水素、酸素-18、炭素-13、窒素-15、その他のタイプ）、エンドユーザー（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断センター、その他のエンドユーザー）

調査対象企業の例（全73件）

  • 3M Company
  • Charles River Laboratories International, Inc.
  • American Elements
  • Bio-Techne Corporation
  • Cambridge Isotope Laboratories, Inc.（CIL）
  • Avanti Polar Lipids, Inc.
  • Biosolve Chimie
  • BOC Sciences
  • Isolife
  • Atlanchim Pharma
  • Eurisotop
  • Curachem, Inc.
  • CORTECNET SAS
  • Electronic Fluorocarbons, LLC
  • Aanshus Innovative Creations

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • 中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15002

Global Stable Isotope Labeled Compounds Market to Reach US$432.5 Million by 2030

The global market for Stable Isotope Labeled Compounds estimated at US$343.5 Million in the year 2024, is expected to reach US$432.5 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$183.4 Million by the end of the analysis period. Growth in the Oxygen-18 segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$129.0 Million While China is Forecast to Grow at 6.1% CAGR

The Stable Isotope Labeled Compounds market in the U.S. is estimated at US$129.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$33.0 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Stable Isotope Labeled Compounds Market - Key Trends & Drivers Summarized

Stable isotope labeled compounds are critical tools in various scientific and industrial applications, including pharmaceuticals, environmental studies, and metabolic research. These compounds, which are labeled with non-radioactive isotopes like carbon-13, nitrogen-15, oxygen-18, and deuterium, enable researchers to trace and study complex biochemical and chemical processes with high precision. The use of stable isotopes provides detailed insights into reaction mechanisms, metabolic pathways, and drug interactions, significantly advancing our understanding of biological systems and environmental dynamics. Unlike radioactive isotopes, stable isotopes pose no radiation hazard, making them safer and more versatile for extensive use in laboratory and industrial settings.

The market for stable isotope labeled compounds is expanding due to the growing demand in pharmaceutical research and development. These compounds are indispensable in the synthesis and testing of new drugs, where they help in determining the pharmacokinetics and metabolic fate of therapeutic agents. In environmental science, stable isotopes are used to track nutrient cycles, carbon flow, and pollution sources, providing essential data for ecological studies and environmental monitoring. The advent of advanced analytical techniques such as nuclear magnetic resonance (NMR) and mass spectrometry has further amplified the utility of stable isotope labeled compounds, enabling more precise and comprehensive analyses.

The growth in the stable isotope labeled compounds market is driven by several factors. Firstly, the increasing investment in pharmaceutical R&D is boosting the demand for these compounds in drug development and metabolic studies. Secondly, advancements in analytical technologies, such as enhanced sensitivity and resolution in mass spectrometry and NMR, are expanding the applications of stable isotope labeled compounds. Thirdly, the rising focus on environmental sustainability and the need for precise ecological monitoring are driving the use of stable isotopes in environmental research. Lastly, regulatory requirements for detailed metabolic and pharmacokinetic data in drug approval processes are further propelling market growth. These factors collectively contribute to the robust expansion of the stable isotope labeled compounds market.

SCOPE OF STUDY:

The report analyzes the Stable Isotope Labeled Compounds market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15, Other Types); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 73 Featured) -

  • 3M Company
  • Charles River Laboratories International, Inc.
  • American Elements
  • Bio-Techne Corporation
  • Cambridge Isotope Laboratories, Inc. (CIL)
  • Avanti Polar Lipids, Inc.
  • Biosolve Chimie
  • BOC Sciences
  • Isolife
  • Atlanchim Pharma
  • Eurisotop
  • Curachem, Inc.
  • CORTECNET SAS
  • Electronic Fluorocarbons, LLC
  • Aanshus Innovative Creations

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • An Introduction to Stable Isotope Labeled Compounds
    • Advantages of Stable Isotope Labeling
    • Radioactive versus Stable Isotopes
    • Global Market Prospects & Outlook
    • Developed Regions Lead, Developing Economies to Fuel Long-term Growth
    • Competition
    • Stable Isotope Labeled Compounds - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Sustained Increase in Research Activities in Pharma and Biotech Sectors Augurs Well for the Market
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Numerous Benefits of Stable Isotope Labelling in Biochemistry Research Propels Market Prospects
    • Focus on Proteomics Research Presents Growth Opportunities for Stable Isotope Labeled Compounds
    • Global Proteomics Market Revenues (in US$ Million) by Geographic Region/Country for 2020 and 2027
    • Rising Prevalence of Cancer Worldwide Drives Market Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rising Adoption of PET Scans for Disease Staging to Support Market Prospects
    • Role of Stable Isotopes in Nuclear Industry & Status of Nuclear Reactors Drives Demand for Stable Isotopes
    • Global Electricity Production Breakdown by Source
    • World Installed Nuclear Power Generation Capacity (in GW) for 2020, 2030, 2040 and 2050
    • Rising Importance of Stable Isotopes Human Nutritional Studies
    • Pharmacokinetic and Metabolic Fate of Drugs: Better Understood with Isotopic Labeling of Metabolites
    • Advancements in Deuterium-Labeled Compounds Synthesis
    • Research Study Investigates Metagenomes' Genetic Capacity to Translate into Production of VOCs of Interest
    • Chemical Tagging Stable Isotope Products for Chemical Labeling
    • Stable Isotope Studies Aid in Integration of Non-essential Amino Acids in Pea Aphids
    • Using Stable Isotopes to Measure Denitrification Rates in Soil
    • Use of Stable Isotopically Labeled Benzene to Evaluate Environmental Exposures
    • Stable Isotope Assisted Technique (LC-MS-Based) Offers Better Metabolites Characterization: A Brief Review
    • Growing Role of Stable Isotopes in Animal Migration Research
    • Recent Labelling Advancements in Organic Molecules
    • Creation of Stable Isotope Labeled Internal Standards
    • Mass Spec Internal Standards: Comparing Different Isotopic Labels
    • Use of Stable Labeled Compounds in the form of Internal Standards
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stable Isotope Labeled Compounds Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Deuterium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Oxygen-18 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Carbon-13 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Nitrogen-15 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche - Key Competitors in the Canada for 2022 (E)
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 65: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 83: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • TABLE 122: India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 146: Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Middle East Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Middle East Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 152: Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Africa Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Africa 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Africa Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Africa 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION